Integra Clinical Research

San Antonio, Texas 78231

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Cognition Disorders, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed
• An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type — Completed
• Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed